InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by McMurdo Matthew Charles. Director active across 3 companies, notably Titan Pharmaceuticals INC. Cumulatively, 6 reports have been published. Activity tracked since 26 July 2023. The latest transaction was disclosed on 25 October 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
McMurdo Matthew Charles is a declarant linked to Titan Pharmaceuticals INC, MINIM, INC. and OPGEN INC, where he is a Director. He has 6 filings in total, and the 6 sampled filings run from 2023-07-28 to 2024-10-01; the modal transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.